hotspot -WSS

hotspot

author：fashion 2025-09-14 18:24:57 - browse：372

Illustration of a red heart. -- health coverage from STAT — Adobe

Novo Nordisk’s obesity drug Wegovy cut the risk of major heart complications by 20% in a closely watched trial, results that could streamline insurance coverage and spur even greater demand for the highly popular therapy.

The milestone Select trial of about 17,500 patients is the first to show that an obesity medication leads to long-term cardiovascular benefits. The company reported only the topline figure in a press release Tuesday, and did not break out the reductions it said were seen in heart attacks, strokes, and cardiovascular deaths — the combined components of the study’s primary outcome. It said all three contributed to the decrease in cardiovascular events in the group that received Wegovy compared with participants given a placebo.

The 20% reduction was greater than many observers were expecting. In a research note Tuesday, Jefferies analysts called the results a “best case” outcome. “If they play baseball in Denmark,” Barclays analyst Emily Field wrote in a note, “Wegovy just hit a home run.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： New oral drug delivery patch is modeled after octopus tentacles

hotspot

WSS

Congress extends some pandemic preparedness programs

Hilary expected to bring catastrophic, life

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Readout Newsletter: Biotech news, Wall Street disappointment, Lilly's drug delays

ProMED sees offers of support, but its future remains unclear

New details revealed about Purdue's marketing of OxyContin

hotspot

hotspot

entertainment

At least 13 dead in Texas as scorching temps continue

Lawsuit highlights wrinkle for disputes over surprise medical bills

Novavax promises a turnaround & Lilly roils the obesity market

WHO recommends second malaria vaccine

23andMe had bad news about my health. I wish a person had delivered it

ProMED sees offers of support, but its future remains unclear

Tori Bowie and the unacceptable rates of Black maternal death

Liz Cheney makes 1st public comment since Trump's election interference indictments

State Dept. review finds Biden bears some blame for Afghanistan failures

6 solutions to address cancer drug shortages and others

explore

Baltimore teen accused of firing into crowd during block party mass shooting

Special counsel raises new conflict of interest concerns for De Oliveira's lawyer

Hilary may become 1st tropical storm to make landfall in California in 84 years

Congress extends some pandemic preparedness programs

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Beware the threat of staffing cuts at the CDC

hotspot

hotspot

explore

focus